Your browser doesn't support javascript.
loading
Seroprevalence of pertussis in Madagascar and implications for vaccination.
Razafimahatratra, Solohery L; Wesolowski, Amy; Rafetrarivony, Lala; Heraud, Jean-Michel; Jones, Forrest K; Cauchemez, Simon; Razafindratsimandresy, Richter; Raharinantoanina, Sandratana J; Harimanana, Aina; Collard, Jean Marc; Metcalf, C J E.
Afiliação
  • Razafimahatratra SL; Bacteriology Experimental Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Wesolowski A; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Rafetrarivony L; Bacteriology Experimental Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Heraud JM; Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Jones FK; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Cauchemez S; Mathematical Modelling of Infectious Diseases Unit, Institute Pasteur, UMR 2000, CNRS, Paris, France.
  • Razafindratsimandresy R; Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Raharinantoanina SJ; Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Harimanana A; Epidemiology and Clinical Research Unit, Institut Pasteur de Madagascar, Madagascar.
  • Collard JM; Bacteriology Experimental Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.
  • Metcalf CJE; Department of Ecology and Evolutionary Biology and Princeton School of Public and International Affairs, Princeton University, Princeton, NJ, USA.
Epidemiol Infect ; 148: e283, 2020 11 16.
Article em En | MEDLINE | ID: mdl-33190665
Pertussis is a highly contagious infectious disease and remains an important cause of mortality and morbidity worldwide. Over the last decade, vaccination has greatly reduced the burden of pertussis. Yet, uncertainty in individual vaccination coverage and ineffective case surveillance systems make it difficult to estimate burden and the related quantity of population-level susceptibility, which determines population risk. These issues are more pronounced in low-income settings where coverage is often overestimated, and case numbers are under-reported. Serological data provide a direct characterisation of the landscape of susceptibility to infection; and can be combined with vaccination coverage and basic theory to estimate rates of exposure to natural infection. Here, we analysed cross-sectional data on seropositivity against pertussis to identify spatial and age patterns of susceptibility in children in Madagascar. A large proportion of individuals surveyed were seronegative; however, there were patterns suggestive of natural infection in all the regions analysed. Improvements in vaccination coverage are needed to help prevent additional burden of pertussis in the country.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacina contra Coqueluche / Estudos Soroepidemiológicos / Coqueluche Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Humans / Infant País/Região como assunto: Africa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacina contra Coqueluche / Estudos Soroepidemiológicos / Coqueluche Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Humans / Infant País/Região como assunto: Africa Idioma: En Ano de publicação: 2020 Tipo de documento: Article